Interleukin 4 co-stimulates the PDGF-BB- and bFGF-mediated proliferation of mesangial cells and myofibroblasts

Nephron

Volumn 92, Issue 4, 2002, Pages 868-880

  Sommer, M ^a   Eismann, U ^a   Gerth, J ^a   Stein, G ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Endothelial cells; Growth factors; Interleukin 4; Mesangial cells; Myofibroblasts; Proliferation; Tubular epithelial cells

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; INTERLEUKIN 4; PLATELET DERIVED GROWTH FACTOR BB; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CATTLE; CELL CULTURE; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROSIS; GLOMERULUS; INFLAMMATION; KIDNEY CORTEX; KIDNEY PARENCHYMA; KIDNEY TUBULE EPITHELIUM; MESANGIUM CELL; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS;

ANIMALS; CATTLE; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; FIBROSIS; GLOMERULAR MESANGIUM; HUMANS; INTERLEUKIN-4; KIDNEY TUBULES; LEUCINE; PLATELET-DERIVED GROWTH FACTOR; PROLINE;

EID: 0036966950     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065451     Document Type: Article

References (54)

1. Kunico GS, Neilson EG, Haverty T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 1991;39:550-556.
2. Müller GA, Schettler V, Müller CA, Strutz F: Prevention of progression of renal fibrosis: How far are we? Kidney Int 1996;49(suppl 54):S75-S82.
3. Strutz F, Neilson EG: The role of lymphocytes in the progression of interstitial disease. Kidney Int 1994;45(suppl 54):S106-S110.
4. Nath KA: The tubulointerstitium in progressive renal disease. Kidney Int 1998;54:992-994.
5. Kovacs EJ: Fibrogenetic cytokines: The role of immune mediators in the development of scar tissue. Immunol Today 1991;12:17-23.
6. Fine LG, Ong ACM, Norman JT: Mechanisms of tubulo-interstitial injury in progressive renal diseases. Eur J Clin Invest 1993;23:259-265.
7. Hogaboam CM, Steinhauser ML, Chensue SW, Kunkel SL: Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int 1998;54:2152-2156.
8. Wardle EN: Renal collagen synthesis and its control. Nephron 1999;83:106-110.
9. Sappino A, Schürch W, Galbiani G: Differentiation repertoire of fibroblastic cells: Expression of phenotypic modulations. Lab Invest 1990; 63:144-161.
10. Alpers CE, Hudkins KL, Floege J, Johnson RJ: Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 1994;5:201-210.
11. Okada H, Inoue T, Suzuki H, Strutz F, Neilson EG: Epithelial-mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo. Nephrol Dial Transplant 2000;15(suppl 6):44-46.
12. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY: Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 1999;56:1455-1467.
13. Johnson RJ, Floege J, Couser WG, Alpers CE: Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 1993;4: 119-128.
14. Ludewig D, Kosmehl H, Sommer M, Böhmer FD, Stein G: PDGF receptor kinase blocker AG 1295 attenuates interstitial fibrosis in rat kidney after unilateral ureteral obstruction. Cell Tissue Res 2000;299:97-103.
15. Sommer M, Schaller R, Fünfstück R, Bohle A, Böhmer FD, Müller GA, Stein G: Abnormal growth and clonal proliferation of fibroblats in an animal model of unilateral ureteral obstruction. Nephron 1999;82:39-50.
16. Elias JA: Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via fibroblast prostaglandin-dependent and -independent mechanisms. Am Rev Respir Dis 11988;38:652-658.
17. Stratford MRL, Watfa RR, Murray C, Martin SG: Determination of collagen and protein turnover by high-performance liquid chromatography. J Chromatog 1990;529:383-395.
18. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslathi E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1. Nature 1990;346: 371-374.
19. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 1994;45:916-927.
20. Clark RAF: Wound repair. Cur Opin Cell Biol 1989;1:1000-1008.
21. Gabbiani G: The biology of the myofibroblast. Kidney Int 1992;41:530-532.
22. Darby I, Skalli O, Gabbiani G: Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990;63:21-29.
23. Fine LG, Ong ACM, Norman JT: Mechanisms of tubulo-interstitial injury in progressive renal diseases. Eur J Clin Invest 1993;23:259-265.
24. Fine LG, Bandyopadhay D, Norman JT: Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int 2000;57(suppl 75):S22-S26.
25. Norman JT, Clark JM, Garcia PL: Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 2000;58:2351-2366.
26. Kirkland G; Paizis K; Wu LL; Katerelos M; Power DA: Heparin-binding EGF-like growth factor mRNA is upregulated in the peri-infarct region of the remnant kidney model: In vitro evidence suggests a regulatory role in myofibroblast transformation. J Am Soc Nephrol 1998; 9:1464-1473.
27. Romagnani S: Th1/Th2 cells. Inflamm Bowel Dis 1999;5:285-294.
28. Nakazato Y, Hayashida T, Kanno Y, Sasamura H, Okada H, Suzuki H, Saruta T: Interleukin (IL)-1 and IL-4 synergistically stimulate NF-IL6 activity and IL-6 production in human mesangial cells. Kidney Int 1998;54:71-79.
29. Taki H, Sugiyama E, Kuroda A, Mino T, kobayashi M: Interleukin-4 inhibits interleukin-11 production by rheumatoid synovial cells. Rheumatology 2000;39:728-731.
30. Knerer B, Formanek M, Temmel A, Martinek H, Schickinger B. Kornfehl J: The role of fibroblasts from oropharyngeal mucosa in producing proinflammatory and mitogenic cytokines without prior stimulation. Eur Arch Otorhinolaryngol 1999;256:266-270.
31. Van den Berg IG, Aten J, Chand A, Claessen N, Dijkind L, Wijdenes J, Lakkis FG, Weening JJ: Interleukin-4 and interleukin 13 act on glomerular visceral epithelial cells. J Am Soc Nephrol 2000;11:413-422.
32. Tipping PG, Kitching AR, Huang XR, Mutch DA, Holdsworth SR: Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol 1997;27:530-537.
33. Postlethwaite AE, Holness MA, Katai H, Raghaw R: Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin-4. J Clin Invest 1992;90: 1479-1485.
34. Salmon-Ehr V, Gillery P, Kalis B, Bancherau J, Maquart FX: Interleukin-4: From B-lymphocyte to fibroblast. Pathol Biol Paris 1996;42: 262-268.
35. Sempowski GD, Beckmann MP, Derdak S, Phipps RP: Subsets of murine lung fibroblasts express membrane bound and soluble IL-4 receptors. J Immunol 1994;152:3606-3613.
36. Johnson RJ, Floege J, Couser WG, Alpers CE: Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 1993;4: 119-128.
37. Johnson RJ, Raines E, FloegeJ, Yoshimura A, Pritzzl P, Alpers CE, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet derived growth factor. J Exp Med 1992;175:1413-1416.
38. Lakkis FG, Baddoura FK, Cruet EN, Parekh KR, Fukunaga M, Munger KA: Anti-inflammatory lymphokine mRNA expression in antibody-induced glomerulonephritis. Kidney Int 1996;49:117-126.
39. Beranek JT, Masseyeff R: Hyperplastic capillaries and their possible involvement in the pathogenesis of fibrosis. Histopathology 1986; 10:543-551.
40. Baradin KA, Desmeth VJ: Ultrastructural observations on sinusoidal endothelial cells in chronic active hepatitis. Histopathology 1992; 9:171-181.
41. Hay ED: An overview of epithelio-mesenchymal transformation. Acta Anat 1995;154:8-20.
42. Yang J, Liu Y: Dissection and key events in intubular epithelial to myofibroblst transition and its implication in renal interstitial fibrosis. Am J Pathol 2001;159:1465-1475.
43. Strutz F: The fibroblast - a (trans-)differentiated cell? Nephrol Dial Transplant 1995;10: 1504-1506.
44. Bohle A, Gise HV, Mackensen-Haen S, Star-Jacob B: The obliteration of the postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Klin Wochenschr 1981;59:1043-1051.
45. Petroll WM, Barry-Lane PA, Cavanagh HD, Jester JV: Z0-1 reorganisation and myofibroblast transformation of corneal endothelial cells after freeze injury in the cat. Exp Eye Res 1997;64:257-267.
46. Nakayima Y, Mironov V, Yamagishi T, Nakamura H, Markwald RR: Expression of smooth muscle alpha-actin in mesenchymal cells during formation of avian endocardial cushion tissue: A role for transforming growth factor beta 3. Dev Dyn 1997;209:296-309.
47. Madri JA, Bell L, Marx M, Merwin JR, Basson C, Prinz Ch: Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: Models of de-endothelization and repair. J Cell Biochem 1991;45:123-130.
48. DeRuiter MC, Poelmann RE, VanMunsteren JC, Mironov V, Markwald RR, Gittenberger-de-Groot AC: Embryonic endothelial cell transdifferentiale into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 1997;80:444-451.
49. Niemir ZI, Ondracek M, Dworacki G, Stein H, Waldherr R, Ritz E, Otto HF: In situ upregulation of IL-10 reflects the activity of human glomerulonephritides. Am J Kidney Diseases 1998;32:80-92.
50. Noronha IL, Krüger C, Andrassy K, Ritz E, Waldherr R: In situ expression of TNF-α, IL-1β and IL-2 in ANCA-positive glomerulonephritis. Kidney Int 1993;43:682-692.
51. Bosswell, Yui MA, Burt DW, Kelly VE: Increased tumor necrosis factor and IL-1β gene expression in kidney of mice with lupus nephritis. J Immunol 1988;141:3050-3054.
52. Sato N, Goto T, Haranaka K, Satomi N, Nariuchi H, Mano-Hirano Y, Sawasaki Y: Action of tumor necrosis factor on cultured vascular endothelial cells: Morphologic modulation, growth inhibition and cytotoxicity. J Nat Cancer Inst 1986;76:1113-1121.
53. Alpers CE, Seifert RA, Hudkin KL, Jahnson RJ, Bowen-Pope DF: PDGF-receptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidney. Kidney Int 1993;43:286-294.
54. Orphanides C, Fine LG, Norman JT: Hypoxia stimulates proximal tubular cell matrix production via a TGF-β1 independent mechanism. Kidney Int 1997;52:637-647.